Carol Moreno

5PUBLICATIONS
15CO-AUTHORS
Haematological tumoursAutoimmunityLiquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 14, 2023
B-cell Receptor Pathway Mutations Are Infrequent in Patients with Chronic Lymphocytic Leukemia on Continuous Ibrutinib Therapy.

Jennifer A Woyach, Paolo Ghia, John C Byrd

|Dec 05, 2021
Long-term efficacy of first-line ibrutinib treatment for chronic lymphocytic leukaemia in patients with TP53 aberrations: a pooled analysis from four clinical trials.

John N Allan, Tait Shanafelt, Adrian Wiestner

|Jun 24, 2021
Autoimmune cytopenia and CLL ride together.

Carol Moreno

|Sep 13, 2019
Final analysis from RESONATE: Up to six years of follow-up on ibrutinib in patients with previously treated chronic lymphocytic leukemia or small lymphocytic lymphoma.

Talha Munir, Jennifer R Brown, Susan O'Brien

|Jun 02, 2018
Changes in clinical stage identify patients with CLL and different outcome within iwCLL partial response: RESONATE study.

Carol Moreno, Julio Delgado, John C Byrd

Pageof 1

Frequent Collaborators

2 joint publications

Susan O'Brien

1 joint publications

Julio Delgado

1 joint publications

Talha Munir

1 joint publications

John N Allan